 |
Recombinant urate oxidase |
|---|---|
| Trade Name | |
| Orphan Indication | Prophylaxis of chemotherapy-induced hyperuricemia |
| USA Market Approval | USA |
| USA Designation Date | 2000-10-11 00:00:00 |
| Sponsor | Sanofi-Synthelabo Research;9 Great Valley Parkway;Malvern, Pennsylvania, 19355 |
